Concepedia

Author

Jan Wierecky

University of Tübingen

Also Known As

J. Wierecky, Jan Wierecky, W. Zeller

29

Publications

756

Citations

8

H-Index

28

Concepts

All Affiliations

University of TübingenPraxis für Hämatologie und OnkologieUniversity of LübeckOnkozentrum Dresden
JW

About

Jan Wierecky is an author at University of Tübingen specializing in medicine, radiation oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

235

2

Health Sciences

2

2

110

3

Immunology

2

2

86

4

Allergy

1

1

13

5

Cell Biology

1

1

13

Jan Wierecky

×

8

Publications

729

Citations

8

H-Index

YearCitations

Immunologic and Clinical Responses after Vaccinations with Peptide-Pulsed Dendritic Cells in Metastatic Renal Cancer Patients

Jan Wierecky, Martin Müller, Stefan Wirths,

Cancer Research

2006

226

Nutrition impact symptoms in advanced cancer patients: frequency and specific interventions, a case–control study

Aurelius Omlin, David Blum, Jan Wierecky,

Journal of Cachexia Sarcopenia and Muscle

2013

154

Human skin mast cells rapidly release preformed and newly generated TNF‐α and IL‐8 following stimulation with anti‐IgE and other secretagogues

Bernhard F. Gibbs, Jan Wierecky, P. Welker,

Experimental Dermatology

2001

114

Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation

Florian Länger, Brigitte Spath, Katja Haubold,

Annals of Hematology

2008

90

Dendritic cell-based cancer immunotherapy targeting MUC-1

Jan Wierecky, Mark Mueller, Peter Brossart

Cancer Immunology Immunotherapy

2005

73

Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer

Jan Wierecky, Christian Kollmannsberger, I. Boehlke,

Journal of Cancer Research and Clinical Oncology

2004

39

Quality of life and outcome of patients with metastatic pancreatic cancer receiving first‐line chemotherapy with nab‐paclitaxel and gemcitabine: Real‐life results from the prospective <scp>QOLIXANE</scp> trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry

Salah‐Eddin Al‐Batran, Ralf‐Dieter Hofheinz, Alexander Reichart,

International Journal of Cancer

2020

20

Cytokine release from a human mast cell line (HMC-1) in response to stimulation with anti-IgE and other secretagogues

Jan Wierecky, Jürgen Grabbe, Helmut H. Wolff,

Inflammation Research

2000

13

Page 1